Orion Health first-half loss widens in line with expectations, revenue climbs 26%

Healthcare system software developer Orion Health Group [NZX: OHE] posted a wider first-half loss.

The company says it is in line with expectations, while a weaker kiwi dollar and recurring revenue in North America lifted sales by 26%.

The loss was $26.9 million, or 16.9c per share, in the six months ended September 30, from a loss of $14.8 million, or 10.9c, a year earlier.

Orion Health is forgoing short-term profits in a bid to build a global business of scale, and as part of that strategy the company is trying to shift more revenue into a recurring sales model, from the traditional perpetual licences it has previously sold.

Revenue rose to $101.7 million in the period, from $80.5 million a year earlier, bolstered by an 8.7% drop in the kiwi dollar on a trade-weighted basis over that period, lifting the value of offshore sales. Had the exchange rate remained unchanged, revenue would have been $13 million lower, Orion says.

Recurring revenue from subscriptions accounted for 41% of sales, up from 30% in 2014. Annualised recurring revenue, a preferred measure for software-as-a-service companies, was $86 million as at Sept. 30, up from $63 million a year earlier.

"The healthcare industry is quickly transforming and changing to keep up with technological and consumer demand," chief executive Ian McCrae says.

"Increasingly, the focus is moving from treating conditions, to treating individuals and when it does Orion Health will have the modern, scalable technology to deliver and enable it."

When Orion Health listed on the stock exchange last year it didn't provide forecasts, saying recurring revenues represented less than a third of sales at the time and there was too much uncertainty about if and when subscription contracts would be signed.

The company's managed services revenue, which covers its recurring subscriber customer base, more than doubled to $21.7 million, driven by sales in North America, the company's biggest market.

Perpetual license revenue advanced 15% to $22.8 million, while support services sales from perpetual licence holders climbed 38% to $19.8 million. Implementation services revenue edged up to $36.3 million.

Orion Health spent $32 million on research and development in the half, up from $23 million a year earlier, largely on an increased headcount and related staff costs. The company has been expanding the capabilities of its existing software and wants to support new cloud-based service models.

"Research remains critical for Orion Health," the company says in its report. "We have for some time been aware that it is necessary to invest in applied research to investigate and develop net intellectual property to support the transformation of healthcare in our markets around the world."

Orion Health had cash and equivalents of $77 million as at September 30, reporting an operational cash outflow of $19.4 million in the half, up from $13.6 million a year earlier. The company raised $120 million of new capital in its initial public offering last year, when it sold shares at $5.70 apiece.

The stock last traded at $3.78, and have dropped 36% this year.

(BusinessDesk)

BusinessDesk receives funding to help cover the commercialisation of innovation from Callaghan Innovation.